Managing myocardial infarction in the diabetic patient

Myocardial infarction (MI) is the leading cause of death among persons with diabetes. Recent advances in the understanding and treatment of cardiovasc ular disease in diabetes have made it increasingly important to tailor ther apy when treating this highrisk population. Because patients with diabetes are at a significantly higher risk of complications and death from MI, thes e patients are most likely to benefit from early and aggressive therapeutic intervention.